Pharmaceutical & Medical Bull 3X Direxion (PILL) |
|
19.46 -0.07 (-0.36%)
|
04-13 09:54 |
|
Open: |
19.41 |
Pre. Close: |
19.53 |
|
High:
|
19.46 |
Low:
|
19.3297 |
|
Volume:
|
5,833 |
Market Cap:
|
0M |
|
|
|
|
The investment seeks daily investment results, before fees and expenses, of 300% of the daily performance of the S&P Pharmaceuticals Select Industry Index.
The fund invests at least 80% of its net assets (plus borrowing for investment purposes) in financial instruments and securities of the index, ETFs that track the index and other financial instruments that provide daily leveraged exposure to the index or ETFs that track the index. The index is a modified equal-weighted index that is designed to measure performance of the stocks comprising the S&P Total Market Index that are classified in the GICS pharmaceuticals sub-industry. The fund is non-diversified. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
20.745 - 20.944 |
20.944 - 21.064 |
|
Low:
|
18.794 - 19.044 |
19.044 - 19.195 |
|
Close:
|
19.242 - 19.651 |
19.651 - 19.898 |
|
Technical analysis |
as of: 2021-04-12 4:58:09 PM |
|
Overall:
|
 |
| Stoxline posted a SELL today, same as yesterday. Downward movement continues. |
| Target: |
Six months: 28.98  One year: 33.03 |
| Support: |
Support1: 19.20 Support2: 15.97 |
| Resistance: |
Resistance1: 24.81 Resistance2: 28.28 |
| Pivot: |
21.61 |
| Moving Average: |
MA(5): 20.49 MA(20): 22.95
MA(100): 24.84 MA(250): 19.53  |
| MACD: |
MACD(12,26): -1.67 Signal(9): -1.49 |
| Stochastic oscillator: |
%K(14,3): 5.22 %D(3): 6.49 |
| RSI: |
RSI(14): 30.94 |
| 52-week: |
High: 31.86 Low: 11.07 Change(%): 58.4 |
| Average Vol(K): |
3-Month: 2534 10-Days: 2567 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.PILL has closed above bottom band by 12.5%. Bollinger Bands are 4.6% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Headline News |
Tue, 13 Apr 2021
New GS1 US Implementation Guideline Helps Pharmaceutical Industry Capture and Share Chain of Custody Data - Yahoo Finance
Tue, 13 Apr 2021
Outlook on the Pharmaceutical Drugs and Biologics Logistics Global Market to 2030 - Identify Growth Segments for Investment - ResearchAndMarkets.com - Business Wire
Tue, 13 Apr 2021
Pharmaceutical Multinationals Miss Out on Online Communication Opportunities, Especially at a Country Level - Valdosta Daily Times
Tue, 13 Apr 2021
Pharmaceutical Contract Manufacturing Market Report 2020-2030 - Yahoo Finance
Tue, 13 Apr 2021
Global Allergic Conjunctivitis Market (2020 to 2027) - Featuring Santen Pharmaceutical, Alcon, Portola Pharmaceuticals and Ocular Therapeutix Among Others - GlobeNewswire
Mon, 12 Apr 2021
Letter: Grateful to pharmaceutical companies’ innovations during pandemic - Chicago Tribune
|
Financial Analysis |
| Growth |
n/a |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
n/a |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
n/a |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
n/a |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Price to Book Value: |
Neutral |
Discounted cash flow: |
Neutral |
| Return on Assets: |
Neutral |
Price to Earnings: |
Neutral |
| Return on Equity: |
Neutral |
Debt to Equity: |
Neutral |
|
